Efficacy of sulforaphane in eradicating Helicobacter pylori in human gastric xenografts implanted in nude mice.

Antimicrob Agents Chemother

Laboratoire de Bactériologie-Virologie, UMR CNRS 75-65, Faculté de Médecine, Université Henri-Poincaré, Vandaeuvre-les-Nancy, France.

Published: December 2003

Sulforaphane, an isothiocyanate abundant in the form of its glucosinolate precursor in broccoli sprouts, has shown in vitro activity against Helicobacter pylori. We evaluated the effect of sulforaphane in vivo against this bacterium by using human gastric xenografts in nude mice. H. pylori was completely eradicated in 8 of the 11 sulforaphane-treated grafts. This result suggests that sulforaphane might be beneficial in the treatment of H. pylori-infected individuals.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC296232PMC
http://dx.doi.org/10.1128/AAC.47.12.3982-3984.2003DOI Listing

Publication Analysis

Top Keywords

helicobacter pylori
8
human gastric
8
gastric xenografts
8
nude mice
8
efficacy sulforaphane
4
sulforaphane eradicating
4
eradicating helicobacter
4
pylori human
4
xenografts implanted
4
implanted nude
4

Similar Publications

Background: The innate immune response aims to prevent pathogens from entering the organism and/or to facilitate pathogen clearance. Innate immune cells, such as macrophages, mast cells (MCs), natural killer cells and neutrophils, bear pattern recognition receptors and are thus able to recognize common molecular patterns, such as pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs), the later occurring in the context of neuroinflammation. An inflammatory component in the pathology of otherwise "primary cerebrovascular and neurodegenerative" disease has recently been recognized and targeted as a means of therapeutic intervention.

View Article and Find Full Text PDF

() is a Gram-negative, spiral-shaped bacterium that colonizes the gastric epithelium and is associated with a range of gastrointestinal disorders, exhibiting a global prevalence of approximately 50%. Despite the availability of treatment options, frequently reemerges and demonstrates increasing antibiotic resistance, which diminishes the efficacy of conventional therapies. Consequently, it is imperative to explore non-antibiotic treatment alternatives to mitigate the inappropriate use of antibiotics.

View Article and Find Full Text PDF

Outer membrane vesicles (OMVs) and exosomes are essential mediators of host-pathogen interactions. Elucidating their mechanisms of action offers valuable insights into diagnosing and treating infectious diseases and cancers. However, the specific interactions of () with host cells via OMVs and exosomes in modulating host immune responses have not been thoroughly investigated.

View Article and Find Full Text PDF

Asia-Pacific Survey on the Management of Helicobacter pylori Infection.

J Gastroenterol Hepatol

December 2024

Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.

Background And Aim: Gastric cancer (GC)-related incidence and mortality rates remain high owing to Helicobacter pylori infection in Asia, and the importance of primary and secondary prevention of GC has been well recognized. We aimed to investigate the extent of overall agreement among clinicians in the Asia-Pacific region regarding the management of H. pylori infection.

View Article and Find Full Text PDF

Pathogenicity and virulence of : A paradigm of chronic infection.

Virulence

December 2025

The Conway Institute of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.

Infection with is one of the most common infections of mankind. Infection typically occurs in childhood and persists for the lifetime of the host unless eradicated with antimicrobials. The organism colonizes the stomach and causes gastritis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!